Galmed Pharmaceuticals Ltd. (GLMD) is a publicly traded Healthcare sector company. As of July 16, 2026, GLMD trades at $0.54 with a market cap of $3.93M and a P/E ratio of 0.00. GLMD moved +5.16% today. Year to date, GLMD is -31.58%; over the trailing twelve months it is -75.07%. Its 52-week range spans $0.41 to $3.61. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces GLMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for GLMD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.54 |
| Market Cap | $3.93M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.61 |
| 52-Week Low | $0.41 |
| Volume | 13.11M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover GLMD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.